Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00345410
Show Display Options
Download search resultsDownload the search results for:
NCT00345410 (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia
Conditions: Obesity;   Dyslipidemia
Intervention: Drug: AVE1625 B

Indicates status has not been verified in more than two years